Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.10 USD
Change Today +1.18 / 1.97%
Volume 1.1M
ALKS On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ALKERMES PLC (ALKS)

Alkermes plc to Report Q1, 2015 on Apr 30, 2015
CapIQ 04/30/2015 12:30 PM ET
Alkermes plc to Report Q4, 2014 on Feb 24, 2015
CapIQ 04/30/2015 12:30 PM ET
Alkermes plc to Report Q3, 2014 on Feb 27, 2014
CapIQ 04/30/2015 12:30 PM ET

2013 revenues at Alkermes plc totaled $596.3M USD, while annual earnings equaled $1.19 per share.

Quarterly Earnings & Estimates - ALKERMES PLC (ALKS)

Actuals vs. Estimates for ALKERMES PLC ALKS

Alkermes plc's Quarterly Earnings

Alkermes plc reported 2nd quarter 2014 earnings of $0.11 per share on 08/2/2014.

Annual Earnings & Estimates - ALKERMES PLC (ALKS)

Actuals vs. Estimates for ALKERMES PLC ALKS

Alkermes plc's Annual Earnings

Alkermes plc reported annual 2013 earnings of $1.19 per share on 03/1/2014.

Quarterly Revenues - ALKERMES PLC (ALKS)

Actuals vs. Estimates for ALKERMES PLC ALKS

Alkermes plc's Quarterly Revenues

Alkermes plc had 2nd quarter 2014 revenues of $153.4M USD. This bettered the $148.2M USD consensus of the 10 analysts covering the company. This was 10.7% above the prior year's 2nd quarter results.

Annual Revenues - ALKERMES PLC (ALKS)

Actuals vs. Estimates for ALKERMES PLC ALKS

Alkermes plc's Annual Revenues

Alkermes plc had revenues for the full year 2013 of $596.3M USD. This was 52.9% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $61.10 USD +1.18

ALKS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cosmo Pharmaceuticals SA SFr.163.70 CHF -2.60
Emergent Biosolutions Inc $31.86 USD +0.11
Jazz Pharmaceuticals PLC $179.35 USD -0.58
Nektar Therapeutics $11.50 USD -0.02
Pacira Pharmaceuticals Inc/DE $78.21 USD -1.87
View Industry Companies
 

Industry Analysis

ALKS

Industry Average

Valuation ALKS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.7x
Price/Book 6.3x
Price/Cash Flow 364.5x
TEV/Sales 12.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.